Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more
Market News Market Pulse Stocks News ETF News Crypto News

Trevi Therapeutics, Inc.

Contributing Author

Recent Articles by Trevi Therapeutics, Inc.

Oct-27
Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference TRVI +6.71% GlobeNewswire
Oct-13
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting TRVI GlobeNewswire
Sep-03
Trevi Therapeutics to Participate in Upcoming September Conferences TRVI GlobeNewswire
Aug-26
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026 TRVI GlobeNewswire
Aug-06
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates TRVI GlobeNewswire
Aug-06
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates TRVI GlobeNewswire
Jul-30
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 TRVI GlobeNewswire
Jul-28
Trevi Therapeutics to Participate in Upcoming August Conferences TRVI GlobeNewswire
Jun-17
Trevi Therapeutics Announces Upcoming June and July Event Schedule TRVI +6.30% GlobeNewswire
May-05
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates TRVI GlobeNewswire
Apr-30
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference TRVI GlobeNewswire
Apr-28
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026 TRVI GlobeNewswire
Apr-23
Trevi Therapeutics to Participate in Upcoming May Events TRVI GlobeNewswire
Apr-20
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares TRVI TRVI -5.06% GlobeNewswire
Apr-16
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock TRVI GlobeNewswire
Apr-16
Trevi Therapeutics Announces Proposed Public Offering of Common Stock TRVI GlobeNewswire
Apr-01
Trevi Therapeutics to Participate in Upcoming Events TRVI GlobeNewswire
Mar-17
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates TRVI GlobeNewswire
Mar-10
Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026 TRVI GlobeNewswire
Mar-09
Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough TRVI -12.03% GlobeNewswire
Mar-02
Trevi Therapeutics to Participate in Upcoming March Conferences TRVI +5.45% GlobeNewswire
Feb-17
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference TRVI GlobeNewswire
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)